Bentham Science Logo

Contents

Current Pharmaceutical Biotechnology, Volume 12 - Number 2


Cell Reprogramming: A New Chemical Approach to Stem Cell Biology and Tissue Regeneration

, 12(2): 146 - 150

L. Anastasia, M. Piccoli, A. Garatti, E. Conforti, R. Scaringi, S. Bergante, S. Castelvecchio, B. Venerando, L. Menicanti and G. Tettamanti


DOI: 10.2174/138920111794295828







Stem Cells: Their Role in Breast Cancer Development and Resistance to Treatment

, 12(2): 196 - 205

A. Nicolini, P. Ferrari, M. Fini, V. Borsari, P. Fallahi, A. Antonelli, P. Berti, A. Carpi and P. Miccoli


DOI: 10.2174/138920111794295657


Parthenogenetic Cell Lines: An Unstable Equilibrium Between Pluripotency and Malignant Transformation

, 12(2): 206 - 212

Tiziana A.L. Brevini, Georgia Pennarossa, Magda de Eguileor, Gianluca Tettamanti, Guido Ragni, Alessio Paffoni and Fulvio Gandolfi


DOI: 10.2174/138920111794295837






Embryonic Morphogenetic Field Induces Phenotypic Reversion in Cancer Cells. Review Article

, 12(2): 243 - 253

M. Bizzarri, A. Cucina, P. M. Biava, S. Proietti, F. D'Anselmi, S. Dinicola, A. Pasqualato and E. Lisi


DOI: 10.2174/138920111794295701





Anabolic Steroid - and Exercise - Induced Cardio-Depressant Cytokines and Myocardial β1 Receptor Expression in CD1 Mice

, 12(2): 275 - 284

Irene Riezzo, Marco Di Paolo, Margherita Neri, Stefania Bello, Santina Cantatore, Stefano D'Errico, Dinuccio Dinucci, Ruggero Parente, Cristoforo Pomara, Roberto Rabozzi, Emanuela Turillazzi and Vittorio Fineschi


DOI: 10.2174/138920111794295792


Synthetic LXR Agonist Suppresses Endogenous Cholesterol Biosynthesis and Efficiently Lowers Plasma Cholesterol

, 12(2): 285 - 292

Thomas Pfeifer, Marlene Buchebner, Prakash G. Chandak, Jay Patankar, Adelheid Kratzer, Sascha Obrowsky, Gerald N. Rechberger, Rajendra S. Kadam, Uday B. Kompella, Gerhard M. Kostner, Dagmar Kratky and Sanja Levak-Frank


DOI: 10.2174/138920111794295774







Webmaster Contact: info@benthamscience.net
Copyright © 2018 Bentham Science